Expression of Hybrid Peptide EF-1 in Pichia pastoris, Its Purification, and Antimicrobial Characterization
Open Access
- 26 November 2020
- Vol. 25 (23) , 5538
Abstract
EF-1 is a novel peptide derived from two bacteriocins, plantaricin E and plantaricin F. It has a strong antibacterial activity against Escherichia coli and with negligible hemolytic effect on red blood cells. However, the chemical synthesis of EF-1 is limited by its high cost. In this study, we established a heterologous expression of EF-1 in Pichia pastoris. The transgenic strain successfully expressed hybrid EF-1 peptide, which had a molecular weight of ~5 kDa as expected. The recombinant EF-1 was purified by Ni2+ affinity chromatography and reversed-phase high performance liquid chromatography (RP-HPLC), which achieved a yield of 32.65 mg/L with a purity of 94.9%. The purified EF-1 exhibited strong antimicrobial and bactericidal activities against both Gram-positive and -negative bacteria. Furthermore, propidium iodide staining and scanning electron microscopy revealed that EF-1 can directly induce cell membrane permeabilization of E. coli. Therefore, the hybrid EF-1 not only preserves the individual properties of the parent peptides, but also acquires the ability to disrupt Gram-negative bacterial membrane. Meanwhile, such an expression system can reduce both the time and cost for large-scale peptide production, which ensures its potential application at the industrial level.Keywords
This publication has 40 references indexed in Scilit:
- Designing antimicrobial peptides: form follows functionNature Reviews Drug Discovery, 2011
- Recombinant production of antimicrobial peptides in Escherichia coli: A reviewProtein Expression and Purification, 2011
- Structure and Mode-of-Action of the Two-Peptide (Class-IIb) BacteriocinsProbiotics and Antimicrobial Proteins, 2009
- Expression and characterization of antimicrobial peptide CecropinAD in the methylotrophic yeast Pichia pastorisProcess Biochemistry, 2009
- Agar and broth dilution methods to determine the minimal inhibitory concentration (MIC) of antimicrobial substancesNature Protocols, 2008
- Expression of a cytotoxic cationic antibacterial peptide in Escherichia coli using two fusion partnersProtein Expression and Purification, 2007
- Expression and purification of a recombinant LL-37 from Escherichia coliBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006
- Tricine–SDS-PAGENature Protocols, 2006
- Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?Nature Reviews Microbiology, 2005
- Two-peptide bacteriocins produced by lactic acid bacteriaBiochimie, 2002